Glamsmile Opens Rome Studio, With the Wenzhou Studio Opening to Follow Shortly Thereafter

   Remedent, Inc. (OTCBB: REMI) an international company specializing in research, development, and the manufacturing of oral care and cosmetic dentistry, opened another Studio in Rome yesterday.

"We are all excited about opening our largest European Studio in Rome yesterday. Rome is one of the major cities of Europe with a population of about 3 million people which relates to about ten times the size of Ghent, our world headquarters. The studio is based in a very affluent part of Rome, not far from the Spanish steps.

For opening week, we already have 4 cases to seat which is an encouraging start to our business in this great capital of the world. The initial responses we have received via our marketing program for Rome and the outlying areas has been very encouraging to say the least.

"We also anticipate that our Studio located in Wenzhou, China will open very soon once the final inspection has been completed. Wenzhou is the birthplace of China's private economy and has a population in excess of 9 million people. In addition to Wenzhou, we are applying for two new leases in greater China pursuant to our plan to expand our Asian Studio operations based on our prior success in Hong Kong, Shanghai and Beijing," said Guy De Vreese, CEO of Remedent.

About Remedent: Remedent Inc. specializes in the research, development, manufacturing and the marketing of oral care and cosmetic dental products. The company serves the professional dental industry with breakthrough technology for dental veneers. These products are supported by a line of professional veneer whitening and tooth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 55 countries world-wide. For more information, go to www. Remedent.be, glamsmile.be and glamsmile.cn

Forward Looking Statements:

Statements in this press release that are "forward looking statement" are based on current expectations that are subject to risks and uncertainties. Such forward looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual results to be materially different from any historical results or from any future results express or implied by such forward looking statements. In addition to these statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "intends," intend," "anticipate, " "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of the factors such as Remedent's ability to achieve the value creation and the results of operations as contemplated by its business plan and objectives, and the risks related to expansion and growth. For further information regarding risks and uncertainties, associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including but not limited to its annual report on Form 10-K and the quarterly reports on 10-Q. We undertake no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.

Contact information: Stephen Ross 310 922-5685 [e-mail]